Health & Nutrition

bg
EU expands Wegovy, Ozempic probe over suicide risks to include other weight loss, diabetes drugs

EU expands Wegovy, Ozempic probe over suicide risks to...

The European Medicines Agency didn't specify which additional GLP-1 drugs are now...

bg
Few patients continue weight loss drugs like Wegovy after a year — but health costs soar for all

Few patients continue weight loss drugs like Wegovy after...

The analysis from Prime Therapeutics highlights the hefty price tag of Wegovy and...

bg
Whistleblower alleges Medtronic engaged in bribery scheme at veterans hospital

Whistleblower alleges Medtronic engaged in bribery scheme...

A recently unsealed lawsuit alleges sales reps from Medtronic, the world’s largest...

bg
Illumina hit with record $476 million fine for closing Grail deal without EU approval

Illumina hit with record $476 million fine for closing...

The European Commission last year blocked Illumina's $7.1 billion acquisition of...

bg
White House unveils plan to eliminate threat of fentanyl laced with xylazine

White House unveils plan to eliminate threat of fentanyl...

The Biden administration declared the dangerous illegal drug cocktail an “emerging...

bg
Novavax stock spikes 29% after company snags $350 million from Canada for unused Covid shots

Novavax stock spikes 29% after company snags $350 million...

Canada's Covid shot settlement is a sign of hope for investors after Novavax raised...

bg
Here's why we're bullish on this mega-cap stock and cautious on this health name

Here's why we're bullish on this mega-cap stock and cautious...

The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.

bg
Microplastics in Seafood and Cancer Risk 

Microplastics in Seafood and Cancer Risk 

Plastic particles may exacerbate the pollutant contamination of fish.  “Plastic...

bg
Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know

Medicare will pay for Alzheimer's drug Leqembi. What patients...

Patients with early Alzheimer's disease could still pay more than $5,000 in out-of-pocket...

bg
Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024

Sales of Alzheimer’s drug Leqembi may be slow initially...

Analysts believe the Medicare registry requirement and new guidance on Leqembi's...